We are live on ! Find out more
JA

John Armitage Egerton Capital (UK)

AUM $10.4B
1-Year Est. Return 25.66%
 

John Armitage is the chief investment officer of Egerton Capital, a London-based long/short equity firm. Egerton is known for fundamental research and a portfolio of high-quality global companies, often with a growth-at-a-reasonable-price tilt. Institutional investors follow the firm for its long track record in developed-market equities.

This Fund
S&P 500
This Quarter Est. Return
+15.85%
1 Year Est. Return
+25.66%
3 Year Est. Return
+136.83%
5 Year Est. Return
+178.53%
10 Year Est. Return
+1,291.99%
AUM
$10.4B
AUM Growth
+$1.34B
Cap. Flow
+$326M
Cap. Flow %
3.15%
Top 10 Hldgs %
76.02%
Holding
29
New
5
Increased
13
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$488M
2
AMZN icon
Amazon
AMZN
+$304M
3
APH icon
Amphenol
APH
+$288M
4
EFX icon
Equifax
EFX
+$252M
5
AMAT icon
Applied Materials
AMAT
+$240M

Sector Composition

Rank Sector Weight
1 Financials 28.95%
2 Technology 20.15%
3 Materials 11.66%
4 Communication Services 11.24%
5 Consumer Discretionary 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNQ icon
26
Canadian Natural Resources
CNQ
$106B
-5,690,211
Closed -$277M
CRS icon
27
Carpenter Technology
CRS
$24.4B
-1,330,920
Closed -$525M
NYT icon
28
New York Times
NYT
$10.6B
-971,884
Closed -$81.4M
RNR icon
29
RenaissanceRe
RNR
$13.4B
-317,308
Closed -$94.3M

Similar funds

John Armitage's Q2 2026 Portfolio in Review

As of Q2 2026, John Armitage held 29 positions worth $10.4B, up 15% from $9.01B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

John Armitage deployed $326M of net new capital in Q2 2026, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was Equifax: 1,481,188 shares worth $235M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 35% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Linde, an estimated $389M trimmed.

  • John Armitage's largest Q2 2026 buy was Equifax: 1,481,188 shares worth $235M.
  • John Armitage added most to Medline Inc in Q2 2026, an estimated $488M increase.
  • John Armitage's biggest Q2 2026 reduction was Linde, cutting an estimated $389M.
  • John Armitage fully exited Carpenter Technology in Q2 2026, selling an estimated $525M.
  • John Armitage's ten largest holdings make up 76% of its $10.4B portfolio in Q2 2026.
  • John Armitage opened 5 new positions and closed 6 in Q2 2026.
  • John Armitage's portfolio value rose 15% quarter-over-quarter to $10.4B.

Based on Egerton Capital (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.